Effects of resveratrol on enrichment of adipose-derived stem cells and their differentiation to osteoblasts in two-and three-dimensional cultures

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue SUPPL. 3, 2012, Pages

  Erdman, Christopher P ^a   Dosier, Christopher R ^a   Olivares Navarrete, Rene ^a   Baile, Clifton ^b   Guldberg, Robert E ^a   Schwartz, Zvi ^a   Boyan, Barbara D ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

3D cell culture; Adipose stem cells; Enrichment; Mesenchymal stem cells; Micro CT; Osteoblasts; Resveratrol; Tissue engineering PCL scaffolds

Indexed keywords

CELL ENGINEERING; CELL PROLIFERATION; COMPUTERIZED TOMOGRAPHY; MINERALOGY; OSTEOBLASTS; PHOSPHATASES; RESVERATROL; SCAFFOLDS (BIOLOGY); STEM CELLS;

3-D CELL CULTURE; ADIPOSE STEM CELLS; ADIPOSE-DERIVED MESENCHYMAL STEM CELLS; CELL/B.E; ENRICHMENT; MESENCHYMAL STEM CELL; MICRO CT; OSTEOPROGENITOR CELLS; TISSUE-ENGINEERING PCL SCAFFOLD; TISSUES ENGINEERINGS;

CELL CULTURE;

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; CD271 ANTIGEN; CD45 ANTIGEN; CELL ANTIGEN; OSTEOCALCIN; POLYCAPROLACTONE; RESVERATROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DEVELOPMENT; BONE MINERALIZATION; CARTILAGE CELL; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; ENRICHMENT CULTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; MALE; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOBLAST; OSTEOGENIC MEDIUM; OSTEOPROGENITOR CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SUBCUTANEOUS FAT; THREE DIMENSIONAL CELL CULTURE; TWO DIMENSIONAL CELL CULTURE;

EID: 84871403099     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.513     Document Type: Article

References (42)

1. Bäckesjö C, Li Y, Lindgren U, et al. 2006; Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Min Res 21: 993-1002.
2. Berardi V, Ricci F, Castelli M, et al. 2009; Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use. J Exp Clin Cancer Res 28: 96.
3. Boissy P, Andersen TL, Abdallah BM, et al. 2005; Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 65: 9943-9952.
4. Caneva L, Soligo D, Cattoretti G, et al. 1995; Immuno-electron microscopy characterization of human bone marrow stromal cells with anti-NGFR antibodies. Blood Cells Mol Dis 21: 73-85.
5. Chen J, Ellison FM, Keyvanfar K, et al. 2008; Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice. Exp Hematol 36: 1236-1243.
6. Danisovic L, Varga I, Polak S, et al. 2009; Comparison of in vitro chondrogenic potential of human mesenchymal stem cells derived from bone marrow and adipose tissue. Gen Physiol Biophys 28: 56-62.
7. De Ugarte DA, Morizono K, Elbarbary A, et al. 2003; Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174: 101-109.
8. Dicker A, Le Blanc K, Astrom G, et al. 2005; Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp Cell Res 308: 283-290.
9. Dominici M, Le Blanc K, Mueller I, et al. 2006; Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
10. Eghbali-Fatourechi GZ, Mödder UI, Charatcharoenwitthaya N, et al. 2007; Characterization of circulating osteoblast lineage cells in humans. Bone 40: 1370-1377.
11. Fraser JK, Wulur I, Alfonso Z, et al. 2006; Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24: 150-154.
12. Gan Y, Dai K, Zhang P, et al. 2008; The clinical use of enriched bone marrow stem cells combined with porous β-tricalcium phosphate in posterior spinal fusion. Biomaterials 29: 3973-3982.
13. Gimble J, Guilak F. 2003; Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5: 362-369.
14. Gindraux F, Obert L, Laganier L, et al. 2010; Industrial approach in developing an advanced therapy product for bone repair. J Tissue Eng Regen Med 4: 194-204.
15. Gronthos S, Franklin DM, Leddy HA, et al. 2001; Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189: 54-63.
16. Guzman R, De Los AA, Cheshier S, et al. 2008; Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 39: 1300-1306.
17. Hayashi O, Katsube Y, Hirose M, et al. 2008; Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int 82: 238-247.
18. Hu J, Feng K, Liu X, et al. 2009; Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network. Biomaterials 30: 5061-5067.
19. Huang C, Ma WY, Goranson A, et al. 1999; Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242.
20. Huang JI, Kazmi N, Durbhakula MM, et al. 2005; Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 23: 1383-1389.
21. Huibregtse BA, Johnstone B, Goldberg VM, et al. 2000; Effect of age and sampling site on the chondro-osteogenic potential of rabbit marrow-derived mesenchymal progenitor cells. J Orthop Res 18: 18-24.
22. Kao CL, Tai LK, Chiou SH, et al. 2009; Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 19: 247-258.
23. Katz A, Tholpady A, Tholpady S, et al. 2005; Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23: 412-423.
24. Kondo T, Kitazawa R, Yamaguchi A, et al. 2008; Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J Cell Biochem 103: 335-345.
25. Lee RH, Kim B, Choi I, et al. 2004; Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14: 311-324.
26. Matsushima A, Kotobuki N, Tadokoro M, et al. 2009; In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on β-tricalcium phosphate. Artif Organs 33: 474-481.
27. Mizutani K, Ikeda K, Kawai Y, et al. 1998; Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 253: 859-863.
28. Peter SJ, Liang CR, Kim DJ, et al. 1998; Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, β-glycerolphosphate, and l-ascorbic acid. J Cell Biochem 71: 55-62.
29. Quirici N, Soligo D, Bossolasco P, et al. 2002; Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30: 783-791.
30. Rayalam S, Della-Fera MA, Yang JY, et al. 2007; Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 137: 2668-2673.
31. Reichert JC, Heymer A, Berner A, et al. 2009; Fabrication of polycaprolactone collagen hydrogel constructs seeded with mesenchymal stem cells for bone regeneration. Biomed Mater 4: 65001.
32. Rider D, Nalathamby T, Nurcombe V, et al. 2007; Selection using the α1-integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells. J Mol Hist 38: 449-458.
33. Robey PG, Kuznetsov SA, Riminucci M, et al. 2007; Skeletal ('mesenchymal') stem cells for tissue engineering. Methods Mol Med 140: 83-99.
34. Vilamitjana-Amedee J, Bareille R, Rouais F, et al. 1993; Human bone marrow stromal cells express an osteoblastic phenotype in culture. In Vitro Cell Dev Biol Anim 29A: 699-707.
35. Wagner W, Wein F, Seckinger A, et al. 2005; Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416.
36. Yamada T, Akamatsu H, Hasegawa S, et al. 2010; Age-related changes of p75 Neurotrophin receptor-positive adipose-derived stem cells. J Dermatol Sci 58: 36-42.
37. Yamamoto N, Akamatsu H, Hasegawa S, et al. 2007; Isolation of multipotent stem cells from mouse adipose tissue. J Dermatol Sci 48: 43-52.
38. Yoshimura H, Muneta T, Nimura A, et al. 2007; Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 327: 449-462.
39. Zhang K, Barragan-Adjemian C, Ye L, et al. 2006; E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol 26: 4539-4552.
40. Zhou H, Shang L, Li X, et al. 2009; Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp Cell Res 315: 2953-2962.
41. Zuk PA, Zhu M, Ashjian P, et al. 2002; Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
42. Zuk PA, Zhu M, Mizuno H, et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.